Comparative studies between a new human rhabdomyosarcoma cell line, JR-1 and its tumour of origin.

por Clayton, J., Pincott, J. R., van den Berghe, J. A., Kemshead, J. T.
Publicado 1986

Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry.

por Papanastassiou, V., Pizer, B. L., Coakham, H. B., Bullimore, J., Zananiri, T., Kemshead, J. T.
Publicado 1993

Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies.

por Kemshead, J. T., Hopkins, K., Pizer, B., Papanastassiou, V., Coakham, H., Bullimore, J., Chandler, C.
Publicado 1998

Magnetic microspheres and monoclonal antibodies for the depletion of neuroblastoma cells from bone marrow: experiences, improvements and observations.

por Kemshead, J. T., Heath, L., Gibson, F. M., Katz, F., Richmond, F., Treleaven, J., Ugelstad, J.
Publicado 1986

Pre-existing anti-mouse immunoglobulin in a patient receiving 131I-murine monoclonal antibody for radioimmunolocalisation.

por Davies, A. G., Bourne, S. P., Richardson, R. B., Czudek, R., Wallington, T. B., Kemshead, J. T., Coakham, H. B.
Publicado 1986

N-myc gene expression and oncoprotein characterisation in medulloblastoma.

por Garson, J. A., Pemberton, L. F., Sheppard, P. W., Varndell, I. M., Coakham, H. B., Kemshead, J. T.
Publicado 1989

Monoclonal antibody 3F8 recognises the neural cell adhesion molecule (NCAM) in addition to the ganglioside GD2.

por Patel, K., Rossell, R. J., Pemberton, L. F., Cheung, N. K., Walsh, F. S., Moore, S. E., Sugimoto, T., Kemshead, J. T.
Publicado 1989

Histological, cytological and immunological analyses are complementary for the detection of neuroblastoma cells in bone marrow.

por Favrot, M. C., Frappaz, D., Maritaz, O., Philip, I., Fontaniere, B., Gentilhomme, O., Bailly, C., Zucker, J. M., Gentet, J. C., Kemshead, J.
Publicado 1986